COVID-19 caused a spike in demand for analgesics, meaning analgesics is expected to see an even stronger increase in retail current value growth in 2020 when compared to 2019. This is due to the fact that the government in Uruguay initially recommended the use of acetaminophen, rather than ibuprofen in terms of treatment of symptoms for COVID-19. As a result, both adult and paediatric acetaminophen experienced solid growth in both current value and retail volume terms in 2020. In fact, COVID-19...

Also Read: http://www.marketwatch.com/story/global-polarized-sunglass-lenses-m...

Euromonitor International's Analgesics in Uruguay report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. Forecasts to 2024 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Also Read: http://www.marketwatch.com/story/global-motorcycle-helmets-market-o...

Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Also Read: http://www.marketwatch.com/story/global-orthopedic-shoes-market-out...

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Table of Content

Analgesics in Uruguay
Euromonitor International
November 2020

Also Read: http://www.marketwatch.com/story/covid-19-outbreak-global-heavy-dut...

List OF CONTENTS AND TABLES

KEY DATA FINDINGS
2020 IMPACT
Consumers gravitate towards acetaminophen in 2020 due to initial government recommendations
Demand for adult and paediatric ibuprofen is moderated in 2020
Major players continue to lead analgesics in 2020, but spike of acetaminophen boosts Gramon Bagó the most
RECOVERY AND OPPORTUNITIES
Potential to develop e-commerce over the forecast period
Ibuprofen set to remain most popular analgesic, but new product development will aid solid growth of acetaminophen
Agreements with mutual pharmacies set to intensify competitive landscape

Also Read: http://www.marketwatch.com/story/global-data-quality-tools-market-i...

CATEGORY DATA
Table 1 Sales of Analgesics by Category: Value 2015-2020
Table 2 Sales of Analgesics by Category: % Value Growth 2015-2020
Table 3 NBO Company Shares of Analgesics: % Value 2016-2020
Table 4 LBN Brand Shares of Analgesics: % Value 2017-2020
Table 5 Forecast Sales of Analgesics by Category: Value 2020-2025
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2020-2025

CONTACT DETAILS :

[email protected]

+44 203 500 2763

+1 62 825 80070

971 0503084105